Current advances in the treatment of myofascial pain syndrome with trigger point injections: A review

Nadia Anwar,Xiong Wei,Yuan Jie,Zhao Hongbo,Hao Jin,Zhaoqiong Zhu
DOI: https://doi.org/10.1097/md.0000000000039885
IF: 1.6
2024-10-09
Medicine
Abstract:The original and most commonly accepted definition of Myofascial pain syndrome (MPS) was developed in 1983 in the trigger point manual by Simons and Travell. MPS is chronic regional pain caused by 1 or more myofascial provocation points (also known as trigger points) (MTrP), which manifest as a highly confined and irritable point of tension in the skeletal muscle or fascia that is palpable and produces localized pressure pain when compressed, and induce pain. [ 1 ] MPS is 1 of the main causes of skeletal muscle pain and dysfunction, and in severe cases, anxiety, depression, and other negative emotions, further affecting the quality of life of patients. Therefore, safely and effectively addressing this problem has been challenging in pain clinics.
medicine, general & internal
What problem does this paper attempt to address?